title: Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy.
abstract: Gene analysis of tumor associated antigens revealed that tumor antigens are all normal gene product. Inducing tumor reactive cytotoxic T lymphocytes (CT) in the patients is same as inducing autoimmunity in the patients. Immunosuppressive cytokine interleukin-10 (IL-10) plays an important role in maintaining homeostasis or tolerance. To break the tumor tolerance, blocking and IL-10 secretion or intervention in the pathways of IL-10 gene activation is indeed important.
authors.affiliation: Department of Medicine, University of Connecticut School of Medicine, Farmington, CT 006030-1628, USA.
authors.forename: Nitya G
authors.initials: NG
authors.lastname: Chakraborty
references.citation: Am J Physiol. 1993 Mar;264(3 Pt 2):H692-700
references.pmid: 8456972
references.citation: J Cell Biol. 1997 Jan 27;136(2):421-31
references.pmid: 9015312
references.citation: Cancer Immunol Immunother. 2005 Dec;54(12):1153-61
references.pmid: 15868167
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8078-82
references.pmid: 7644541
references.citation: Blood. 1995 Jan 15;85(2):307-18
references.pmid: 7811987
references.citation: Pathobiology. 2008;75(3):200-8
references.pmid: 18550918
references.citation: Annu Rev Immunol. 2006;24:175-208
references.pmid: 16551247
references.citation: Curr Mol Med. 2003 Dec;3(8):693-706
references.pmid: 14682491
references.citation: Eur J Immunol. 1999 Jun;29(6):2014-25
references.pmid: 10382765
references.citation: J Exp Med. 1991 Nov 1;174(5):1209-20
references.pmid: 1940799
references.citation: J Immunol. 1987 Dec 15;139(12):4042-8
references.pmid: 2826576
references.citation: Eur J Immunol. 1992 Mar;22(3):711-7
references.pmid: 1547817
references.citation: J Immunol. 1999 May 1;162(9):5576-83
references.pmid: 10228040
references.citation: Biochem J. 1992 Jul 15;285 ( Pt 2):345-65
references.pmid: 1637327
references.citation: J Immunol. 1992 Jul 1;149(1):92-5
references.pmid: 1607665
references.citation: Hum Immunol. 2004 Aug;65(8):794-802
references.pmid: 15336780
references.citation: J Immunol. 2005 Nov 15;175(10):6458-64
references.pmid: 16272299
references.citation: Microsc Res Tech. 2001 Feb 15;52(4):387-95
references.pmid: 11170297
references.citation: Immunity. 2004 Jan;20(1):107-18
references.pmid: 14738769
references.citation: J Immunol. 1993 Jan 15;150(2):353-60
references.pmid: 8419468
references.citation: J Immunol. 1989 Sep 15;143(6):1815-21
references.pmid: 2550543
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Int J Cancer. 1993 Aug 19;55(1):96-101
references.pmid: 8344757
references.citation: J Immunol. 2006 Jan 15;176(2):984-90
references.pmid: 16393984
references.citation: Nature. 1997 Oct 16;389(6652):737-42
references.pmid: 9338786
references.citation: Proc Natl Acad Sci U S A. 1990 Feb;87(4):1486-90
references.pmid: 2137615
references.citation: Med Oncol. 1999 Jul;16(2):86-94
references.pmid: 10456656
references.citation: Blood. 1989 Jul;74(1):19-25
references.pmid: 2473795